Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Microbial Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Gibberella intermedia method for steroid intermediates. High yield conversion reduces manufacturing costs and ensures supply chain reliability for pharmaceutical partners globally.
Patent CN102876582B details a novel Metarhizium anisopliae strain for efficient 11α-hydroxylation. This biocatalytic route offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN109680032B reveals a high-yield microbial route for steroid hydroxylation. Discover cost-effective manufacturing and reliable supply chain solutions for pharmaceutical intermediates.
Patent CN117431292B reveals a high-yield one-step fermentation for 8DM. Discover cost reduction in steroid manufacturing and reliable supply chain solutions.
Patent CN102719496B reveals immobilized yeast catalysis for (S)-(+)-ethyl mandelate. Offers high ee value, mild conditions, and scalable green manufacturing for global supply chains.
Patent CN102719497B details an immobilized yeast method for high-purity methyl (S)-(+)-mandelate. Offers green manufacturing and cost reduction for chiral intermediates.
Patent CN109609582A reveals microbial deracemization for L-glufosinate-ammonium. Achieve high purity and cost reduction in herbicide manufacturing with scalable biocatalysis.
Novel Mycobacterium neoaurum enables high-yield 9-OH AD production with simplified purification for reliable pharmaceutical intermediate supply chains and cost efficiency.
Patent CN109609582B reveals a novel microbial deracemization route for L-glufosinate-ammonium, offering superior purity and cost-effective supply chain solutions.
Patent CN100376681C details a microbial asymmetric reduction method for (R)-mandelic acid using Saccharomyces cerevisiae, offering a green, cost-effective alternative to traditional chemical resolution for pharmaceutical manufacturing.
Patent CN106520896B reveals one-step fermentation for 8DM. Enhances yield and reduces solvent use for reliable pharmaceutical intermediates supply chains.
Patent CN102465159B details a green microbial route for Eslicarbazepine. Enhance supply chain reliability and reduce manufacturing costs with this scalable biocatalytic technology.
Patent CN102465159B enables green microbial synthesis. Reduces cost and improves supply chain reliability for epilepsy drug intermediates significantly.
Patent CN106520890B reveals a novel two-phase fermentation method using Aspergillus ochraceus for efficient steroid dehydrogenation, offering significant cost reduction in API manufacturing.
Patent CN105779555B details a one-step microbial conversion for prednisolone intermediates, offering significant cost reduction and supply chain efficiency for pharmaceutical manufacturers.
Novel Bacillus megaterium strain enables high-purity R-4-chloro-3-hydroxybutyrate production with reduced costs and environmental impact.
Patent CN100385007C details a microbial method for (R)-mandelic acid using Brevibacterium flavum, offering high optical purity and scalable biocatalysis for pharma intermediates.
Patent CN101824438B details microbial synthesis of high-purity (S)-EHB using yeast. Offers cost-effective, scalable pharmaceutical intermediate solutions.
Patent CN102816825A reveals a novel microbial fermentation route for DHEA from plant sterols, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Discover how biocatalytic synthesis of chiral pseudonucleosides offers superior enantioselectivity, reduced waste, and cost-effective production for your antiviral and antitumor drug development.